Research Summary

Dr.Hyunseok "Hyu" Kang is a medical oncologist and a clinician scientist focusing on head and neck cancers including squamous cell carcinomas of head and neck (SCCHN), salivary gland cancers, thyroid cancers and other rare cancers of head and neck. Dr.Kang joined UCSF from the Johns Hopkins University School of Medicine in Baltimore, MD where he was an Assistant Professor of Oncology, Otolaryngology - Head and Neck Surgery.

Dr.Kang completed his medical degree and public health degree at Yonsei University in Seoul, South Korea, then came to the US and had residency training at St.Luke's Roosevelt Hospital Center/Columbia University in New York City. He completed hematology and medical oncology fellowship at Emory University in Atlanta, GA.

Dr.Kang's research focus is development of clinical trials with novel therapeutic agents for patients with head and neck cancers. He has conducted/participated a number of clinical trials with immune checkpoint inhibitors and targeted therapy agents.


Yonsei University College of Sciences, Seoul, Korea, Premed Cert, 02/1998, Premedical Sciences
Yonsei University College of Medicine, Seoul, Korea, M.D., 02/2002, Medicine
Yonsei University Graduate School of Public Health, Seoul, Korea, M.P.H., 08/2007, Epidemiology and Statistics
St.Luke’s-Roosevelt Hospital Center/Columbia University College of P&S, New York, NY, Postdoctoral 06/2010 Internal Medicine Residency
Emory University School of Medicine, Atlanta, GA, Postdoctoral. 06/2013, Hematology/Oncology Fellowship

Honors & Awards

  • 2005
    Excellence in Public Health Service, Ministry of Health and Welfare, South Korea
  • 2012
    Travel Award, AACR/ASCO Methods in Clinical Research, Vail, CO

Selected Publications

  1. Cui Z, Kang H, Grandis JR, Johnson DE CYLD Alterations in the Tumorigenesis and Progression of Human Papillomavirus-Associated Head and Neck Cancers.  View on PubMed
  2. Wirth LJ, Sherman E, Robinson B, Solomon B, Kang H, Lorch J, Worden F, Brose M, Patel J, Leboulleux S, Godbert Y, Barlesi F, Morris JC, Owonikoko TK, Tan DSW, Gautschi O, Weiss J, de la Fouchardière C, Burkard ME, Laskin J, Taylor MH, Kroiss M, Medioni J, Goldman JW, Bauer TM, Levy B, Zhu VW, Lakhani N, Moreno V, Ebata K, Nguyen M, Heirich D, Zhu EY, Huang X, Yang L, Kherani J, Rothenberg SM, Drilon A, Subbiah V, Shah MH, Cabanillas ME Efficacy of Selpercatinib in RET-Altered Thyroid Cancers.  View on PubMed
  3. Park JC, Durbeck J, Boudadi K, Ho WJ, Kang H The efficacy of anti-PD-1 immune checkpoint inhibitor in nasopharyngeal carcinoma.  View on PubMed
  4. Jung K, Narwal M, Min SY, Keam B, Kang H Squamous cell carcinoma of head and neck: what internists should know.  View on PubMed
  5. Kurzrock R, Bowles DW, Kang H, Meric-Bernstam F, Hainsworth J, Spigel DR, Bose R, Burris H, Sweeney CJ, Beattie MS, Blotner S, Schulze K, Cuchelkar V, Swanton C Targeted therapy for advanced salivary gland carcinoma based on molecular profiling: results from MyPathway, a phase IIa multiple basket study.  View on PubMed
  6. Muzzey D, Kash S, Johnson JI, Melroy LM, Kaleta P, Pierce KA, Ready K, Kang HP, Haas KR Software-Assisted Manual Review of Clinical Next-Generation Sequencing Data: An Alternative to Routine Sanger Sequencing Confirmation with Equivalent Results in >15,000 Germline DNA Screens.  View on PubMed
  7. Park JC, Ma TM, Rooper L, Hembrough T, Foss RD, Schmitt NC, Sawhney R, Flanders A, Kang H Exceptional responses to pertuzumab, trastuzumab, and docetaxel in human epidermal growth factor receptor-2 high expressing salivary duct carcinomas.  View on PubMed
  8. Lu JT, Ferber M, Hagenkord J, Levin E, South S, Kang HP, Strong KA, Bick DP Evaluation for Genetic Disorders in the Absence of a Clinical Indication for Testing: Elective Genomic Testing.  View on PubMed
  9. Park JC, Gourin CG, Kiess AP, Mehra R, Forastiere AA, Kang H Pattern of planned systemic therapy usage in newly diagnosed, nonmetastatic squamous cell carcinoma of the head and neck in a commercially insured population in the United States.  View on PubMed
  10. Kang H, Pettinga D, Schubert AD, Ladenson PW, Ball DW, Chung JH, Schrock AB, Madison R, Frampton GM, Stephens PJ, Ross JS, Miller VA, Ali SM Genomic Profiling of Parathyroid Carcinoma Reveals Genomic Alterations Suggesting Benefit from Therapy.  View on PubMed
  11. Kwatra SG, Ständer S, Kang H PD-1 Blockade-Induced Pruritus Treated with a Mu-Opioid Receptor Antagonist.  View on PubMed
  12. Karantanos T, Rooper L, Kang Y, Lin CT, Wenga P, Sagorsky S, Lauring J, Kang H Clinical Benefit to an Aurora A Kinase Inhibitor in a Patient with Metastatic Integrase Interactor 1-Deficient Carcinoma.  View on PubMed
  13. Ho WJ, Yarchoan M, Hopkins A, Mehra R, Grossman S, Kang H Association between pretreatment lymphocyte count and response to PD1 inhibitors in head and neck squamous cell carcinomas.  View on PubMed
  14. Jung K, Park JC, Kang H, Brandes JC Androgen deprivation therapy is associated with decreased second primary lung cancer risk in the United States veterans with prostate cancer.  View on PubMed
  15. Rooper LM, Karantanos T, Ning Y, Bishop JA, Gordon SW, Kang H Salivary Secretory Carcinoma With a Novel ETV6-MET Fusion: Expanding the Molecular Spectrum of a Recently Described Entity.  View on PubMed
  16. Mehra R, Seiwert TY, Gupta S, Weiss J, Gluck I, Eder JP, Burtness B, Tahara M, Keam B, Kang H, Muro K, Geva R, Chung HC, Lin CC, Aurora-Garg D, Ray A, Pathiraja K, Cheng J, Chow LQM, Haddad R Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012.  View on PubMed
  17. Kang H, Antonarakis ES, Luo J, Zheng Q, Rooper L, De Marzo AM, Westra WH, Lotan TL Detection of AR-V7 transcript with RNA in situ hybridization in human salivary duct cancer.  View on PubMed
  18. Ho WJ, Rooper L, Sagorsky S, Kang H A robust response to combination immune checkpoint inhibitor therapy in HPV-related small cell cancer: a case report.  View on PubMed
  19. Motz K, Herbert RJ, Fakhry C, Quon H, Kang H, Kiess AP, Eisele DW, Koch WM, Frick KD, Gourin CG Short- and long-term outcomes of oropharyngeal cancer care in the elderly.  View on PubMed
  20. Gourin CG, Herbert RJ, Fakhry C, Quon H, Kang H, Kiess AP, Koch WM, Eisele DW, Frick KD Quality indicators of oropharyngeal cancer care in the elderly.  View on PubMed

Go to UCSF Profiles, powered by CTSI